Education
About Us
Working with TipRanks
Follow Us
Creo Medical (GB:CREO)
:CREO
CREO Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.22p - 37.00p
Previous CloseN/A
Volume60.81K
Average Volume (3M)2.11M
Market Cap
£58.26M
Enterprise Value147.25M
Total Cash (Recent Filing)£9.80M
Total Debt (Recent Filing)£14.20M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Oct 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding412,473,330
10 Day Avg. Volume1,899,338
30 Day Avg. Volume2,106,767
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.96
Price to Sales (P/S)0.00
P/FCF Ratio-1.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Creo Medical News
PremiumCompany Announcements
Creo Medical Chairman Increases Stake with Significant Share Purchase
PremiumCompany Announcements
Creo Medical Publishes 2024 Annual Report and Announces AGMPremiumCompany Announcements
Creo Medical Achieves Key U.S. Reimbursement Milestone for ESD Procedures
PremiumCompany Announcements
M&G Plc Increases Stake in Creo Medical Group
PremiumCompany Announcements
M&G Plc Increases Stake in Creo Medical Group
PremiumCompany Announcements
Creo Medical Announces Board Changes Amid Leadership Transition
PremiumCompany Announcements
Creo Medical Announces Board Changes Amidst Leadership TransitionOptions Prices
Currently, No data available
---
Ownership Overview
3.47% Insiders
―
Mutual Funds
― Other Institutional Investors
96.53% Public Companies and
Individual Investors
CREO FAQ
What was Creo Medical’s price range in the past 12 months?
Creo Medical lowest share price was 9.22p and its highest was 37.00p in the past 12 months.
What is Creo Medical’s market cap?
Creo Medical’s market cap is £58.26M.
When is Creo Medical’s upcoming earnings report date?
Creo Medical’s upcoming earnings report date is Oct 06, 2025 which is in 113 days.
How were Creo Medical’s earnings last quarter?
Currently, no data Available
Is Creo Medical overvalued?
According to Wall Street analysts Creo Medical’s price is currently Overvalued.
Does Creo Medical pay dividends?
Creo Medical does not currently pay dividends.
What is Creo Medical’s EPS estimate?
Creo Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Creo Medical have?
Creo Medical has 412,473,330 shares outstanding.
What happened to Creo Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Creo Medical?
Currently, no hedge funds are holding shares in GB:CREO
Creo Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GB:CREO Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth £110.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.26%
12-Months-Change
Fundamentals
Return on Equity
-38.49%
Trailing 12-Months
Asset Growth
-21.87%
Trailing 12-Months
Company Description
Creo Medical
Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.
Technical Analysis
RUA Life Sciences
―
Inspiration Healthcare
―
Tissue Regenix
―
Belluscura PLC
―
Ondine Biomedical, Inc.
―